RP59500 (Quinupristin/dalfopristin): Three case reports of its use in infection due to Enterococcus faecium

J. Cassell, I. Balakrishnan, D. Samarasinghe, P. Mistry, H. G. Prentice, S. H. Gillespie*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)

Abstract

We describe three cases of Entercoccus faecium sepsis arising in immunocompromised patients, severely ill with other conditions, who were treated with the new injectable streptogramin RP59500. There are still few reports of clinical experience with this drug. All had bacteriological resolution, with one patient recovering fully. Although two of the three patients died, this was due to underlying disease in one case and a Gram-negative superinfection in another. Quinupristin/dalfopristin therapy was not associated with significant adverse effects in any of the patients.

Original languageEnglish
Pages (from-to)324-327
Number of pages4
JournalJournal of Infection
Volume36
Issue number3
DOIs
Publication statusPublished - 1 Jan 1998

Fingerprint

Dive into the research topics of 'RP59500 (Quinupristin/dalfopristin): Three case reports of its use in infection due to Enterococcus faecium'. Together they form a unique fingerprint.

Cite this